U.S. Markets open in 7 hrs, 44 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,632.38 | 29.88 | 0.26% |
| NASDAQ | 2,325.88 | 21.92 | 0.95% |
| S&P 500 | 1,282.19 | 5.19 | 0.41% |
| Day Low 01:20 PM EDT | 0.74 | |
|---|---|---|
| Day High 11:22 AM EDT | 0.75 |
|
| Range | 0.01 | |
| Volume | 6,166 | |
| 30-Day Avg. Vol. | — |
|
| Difference | — | |
| Market Cap. | 40.64 M | |
| Change | -549,240 | |
| Shares Out. | 54.77 M | |
| Percent Traded | 0.01% | |
| Revenue | — | |
| Earnings | — | |
| EPS (TTM) | -0.47 |
| 52-Wk Low 6/18/08 | 0.55 | |
|---|---|---|
| 52-Wk High 11/2/07 | 2.00 |
|
| Range | 1.45 | |
| Prev. Close 7/22/08 | 0.75 | |
| Today's Open | 0.75 | |
| Change | 0.00% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 1.6196 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
Aradigm helps the medicine go down for people who swoon at the sight of a needle. Aradigm develops orally-inhaled drug delivery systems that treat respiratory diseases. Its lead delivery technology, AERx ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.10 12/31/07 | -0.13 12/31/07 |
-0.03
Missed
|
| Last Quarter | -0.135 3/31/08 | -0.10 3/31/08 |
0.035
Beat
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
Real-Time Quote
